An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine

Author(s):
Baakman, A.C.; Alvarez-Jimenez, R.; Rissmann, R.; Klaassen, E.S.; Stevens, J.; Goulooze, S.C.; Burger, J.C.G. den; Swart, E.L.; Gerven, J.M.A. van (0000-0002-1444-7415); Groeneveld, G.J.
Published
2017
Publication type
Article / Letter to editor
clinical trialsdrug developmentneuropharmacologypharmacotherapy
Date issued
2017-08-31
Language
English
Is part of
British Journal of Clinical Pharmacology (2017), Vol. 83, no. 8, p. 1676-1687
hdl
1887/115701
doi
10.1111/bcp.13268